New, proprietary technology from PacBio delivers a 10 to 100-fold increase in accuracy over traditional short-read sequencing platforms. With enhanced sensitivity and reduced sequencing depth, PacBio short-read sequencing technology empowers cancer researchers to see what they haven’t been able to before.
In this webinar, learn about game-changing liquid biopsy research capabilities made possible by the Onso sequencing system and powered by proprietary sequencing by binding (SBB) chemistry.
Watch the recording to:
Register to watch recording